Suraj Muley, M.D., FAAN, FRCP

Suraj Muley, M.D., FAAN, FRCP

  • Bob Bove Neuroscience Institute — Neurology — Medical Director
  • ASU School of Medicine and Advanced Medical Engineering — Medicine — Professor
  • University of Arizona College of Medicine — Neurology — Professor
Research Division
Programs

Biography

Dr. Suraj Ashok Muley, M.D., FAAN, FACP, FRCP, is a nationally and internationally recognized neuromuscular neurologist with over 25 years of academic and clinical leadership in the U.S.

He is Professor of Medicine, ASU School of Medicine and Advanced Medical Engineering; Professor of Neurology at the U of A College of Medicine; and Director of Neurology at the Bob Bové Neuroscience Institute at HonorHealth in Scottsdale, Ariz. A former Division Director at Barrow Neurological Institute, he has held multiple faculty roles at leading institutions, including the University of Minnesota and University of California Davis.

Dr. Muley completed his medical education at Seth G.S. Medical College, Bombay, followed by advanced training in neurology, neurophysiology, and neuromuscular medicine in the U.S. He is triple board-certified and has led numerous NIH- and industry-sponsored clinical trials in myasthenia gravis, CIDP, and other neuromuscular disorders.

A prolific researcher and sought-after speaker, Dr. Muley has over 60 peer-reviewed publications, numerous invited lectureships, and leadership roles in national societies, including the Myasthenia Gravis Foundation of America and the American Clinical Neurophysiology Society. He is also a Fulbright Senior U.S. Scholar in Neuroscience.

With recognized expertise in autoimmune neuromuscular disease and peripheral neuropathy, Dr. Muley combines clinical innovation with a deep commitment to education and translational research. He is a Fellow of the American Academy of Neurology, American College of Physicians, and Royal College of Physicians of Edinburgh.

Research Interests & Focus

Suraj’s academic and clinical research is centered on immune-mediated neuromuscular disorders, particularly chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis (MG), and multifocal motor neuropathy (MMN). Over the past two decades, he has led and participated in numerous pivotal clinical trials, investigating novel immunotherapies and optimizing treatment paradigms in CIDP and MG. His work has contributed to improving treatments of these conditions.
Suraj’s interest in translational neuroimmunology stems from an early background in pharmacology and has evolved through a career focused on elucidating mechanisms of peripheral nerve injury and repair, immunopathogenesis of neuromuscular disorders, and electrophysiological phenotyping. He has conducted investigator-initiated trials, including the use of pulsed steroids and subcutaneous immunoglobulin in CIDP and MG, and contributed to landmark multicenter studies in these diseases.
In parallel, he remains committed to developing clinical tools that improve diagnostic sensitivity, especially in challenging and overlapping neuropathy syndromes. He has led prospective registries and longitudinal cohorts to assess disease progression, treatment response, and patient-reported outcomes in real-world settings. Recent work includes early experience with FcRn inhibitors and complement blocking therapies and identifying predictors of treatment failure or relapse.
Suraj also is passionate about mentoring the next generation of clinician-scientists in neuromuscular medicine. As a Fulbright Senior Scholar in Neuroscience, his aim is to bridge global disparities in neuromuscular research and care.
At this stage in his career, his research continues to focus on integrating clinical, electrophysiological, and immunological data to personalize therapy and improve long-term outcomes in patients with autoimmune neuromuscular diseases.